Condition: Bicuspid Aortic Valve (BAV) · Sponsor: Ruijin Hospital
Pervious studies indicated that the prevalence of bicuspid aortic valve（BAV） might be higher in China. There is a familial predisposition to the development of BAV. The study analyzed epidemiological data on selected BAV and established a BAV cohort to observe disease progression and treatment outcomes.
This description comes directly from the study's public registry record.
Wenli Zhang, MD · +86 (021)64370045 · zwl11929@rjh.com.cn
Always discuss trial participation with your own doctor first.
| Ruijin hospital, Shanghai JiaoTong University School of Medicine | Shanghai, Shanghai Municipality, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06802016